Skip to main content

Advertisement

Table 1 Prognostic clinicopathologic variables as predictors of disease-specific survival in 335 NSCLC-patients

From: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival

Characteristics Patients N, (%) Median survival (months) 5-year survival (%) P
Age     .421
≤65 years 156 (47) 98 56  
>65 years 179 (53) NR 60  
Sex     .220
Female 82 (24) 190 64  
Male 253 (76) 98 56  
Smoking status     .257
Never 15 (5) 19 43  
Previous 105 (31) 84 55  
Present 215 (64) NR 60  
Performance status     .016
0 197 (59) NR 63  
1 120 (36) 64 52  
2 18 (5) 25 33  
Weight loss     .759
<10 % 303 (90) 190 58  
>10 % 32 (10) 98 57  
Histology     .028
Squamous cell carcinoma 191 (57) NR 66  
Adenocarcinoma 113 (34) 54 46  
Large cell carcinoma 31 (9) 98 56  
Differentiation     <.001
Poor 138 (41) 47 47  
Moderate 144 (43) 190 65  
Well 53 (16) NR 68  
Surgical procedure     0.007
Wedge + Lobectomy 243 (73) 190 62  
Pneumectomy 92 (27) 37 47  
Pathological stage     <.001
pI 157 (47) NR 72  
pII 136 (41) 62 51  
pIIIA 42 (12) 17 24  
Tumor stage     <.001
1 85 (25) 190 75  
2 188 (56) 84 57  
3 62 (19) 25 37  
Nodal stage     <.001
0 232 (69) NR 67  
1 76 (23) 35 43  
2 27 (8) 18 18  
Surgical margins     .374
Free 307 (92) 190 59  
Not free 28 (8) 47 48  
Vascular infiltration     <.001
No 284 (85) 190 62  
Yes 51 (15) 27 33  
  1. NR, not reached; NCSLC, non-small cell lung cancer